Congress Wants Drug Makers to Explain Price Increases

by Admin | September 29, 2015 1:10 pm

September 29, 2015—Eighteen members of the House Oversight and Government Reform Committee have asked Chairman Jason Chaffetz (R-Utah) to “issue a subpoena compelling Valeant Pharmaceuticals to turn over documents the company is withholding from Congress relating to massive price increases earlier this year for two drugs used by hospitals and other providers to treat serious heart conditions.”

You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register[1]. Already registered? Click here to login[2]. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)

Endnotes:

Click here to register: https://secure.340bhealth.org/340Binformed/Subscribe.aspx
Click here to login: http://340binformed.org/reader-login/

Source URL: https://340binformed.org/2015/09/congress-wants-drug-makers-to-explain-price-increases/